MENU

GNGBY Stock Getinge AB (GNGBY, $16.83) RSI Indicator left the oversold zone on November 12, 2024

A.I.dvisor
at Tickeron.com
Loading...
GNGBY - Getinge AB
RSI signal
Bullish Trend
Odds of UP Trend
Tickeron
RSI signal
Price: $16.83
Daily change: -$0.73 (-4.16%)
Daily volume: 46.5K
Capitalization: $4.8B
Industry: Medical Specialties
This is a signal that GNGBY's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. A.I.dvisor looked back and found 27 similar cases where GNGBY's RSI Indicator left the oversold zone, and in of them led to a successful outcome. Odds of Success:

GNGBY in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 18, 2024

GNGBY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where GNGBY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GNGBY's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 05, 2024. You may want to consider a long position or call options on GNGBY as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GNGBY just turned positive on November 29, 2024. Looking at past instances where GNGBY's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNGBY advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for GNGBY moved below the 200-day moving average on November 22, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNGBY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GNGBY entered a downward trend on December 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.729) is normal, around the industry mean (23.300). P/E Ratio (24.876) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (23.058) is also within normal values, averaging (5.667). Dividend Yield (0.022) settles around the average of (0.018) among similar stocks. P/S Ratio (1.802) is also within normal values, averaging (43.338).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GNGBY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNGBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Lindholmspiren 7A
Phone
+46 103350000
Employees
10989
Web
https://www.getinge.com